Auricular Acupuncture as Effective Pain Relief After Episiotomy

May 11, 2018 updated by: Andro Košec, MD, PhD, University Hospital "Sestre Milosrdnice"

Auricular Acupuncture as Effective Pain Relief After Episiotomy: A Prospective Interventional Randomized Parallel Single-center Study

Background: Episiotomy is performed in up to 30% of vaginal deliveries. Previously, pain treatment following episiotomy has relied on non-steroid anti-inflammatory drugs (NSAID) as analgesics, whose use during breastfeeding remains controversial due of their transfer to the child through lactation. The aim of the study is to determine the effect of acupuncture on postpartal perineal pain following episiotomy.

Methods: The study is designed as a prospective interventional randomized parallel single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy. The population will encompass 60 patients that have had mediolateral episiotomy performed during vaginal delivery, with 29 receiving acupuncture therapy and 31 not receiving acupuncture therapy for pain relief. NSAID analgesic therapy will be made available per request.

Study Overview

Detailed Description

Study Protocol The study is designed as a prospective interventional randomized parallel longitudinal single-center study to evaluate the effects of auricular acupuncture on pain relief after episiotomy conducted in the Department of Gynecology and Obstetrics, University Hospital Center Sestre milosrdnice, Zagreb, Croatia. This institution performs up to 3100 deliveries per year. Episiotomy is indicated and performed in 30% of them.

Prospective data will be collected from November 2016 to April 2017. The study will include healthy pregnant women over 18 years of age, a minimum of 36 weeks' gestation that underwent mediolateral episiotomy during vaginal delivery. Sixty patients will be included in the study. Half of patients will be treated with auricular acupuncture for episiotomy pain relief and oral analgesics, while the other half will be treated with oral analgesics only. In both groups, administration of oral analgesics was recorded. The patients will be allocated to the groups by using a heads-tails coin toss.

In this study, auricular acupuncture will be used. The acupuncture treatment consists of three acupuncture needles on the dominant ear according to French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point that is used to increase the anaesthetic effect according to both French and Chinese traditions (14,15). Acupuncture needles will be stimulated by manual rotation of the needle to evoke needle sensation De Qi. No electrostimulation will be used. Sterile 0,2 x 1,4 mm needles were used. The needles will be inserted within 6-8 hours after childbirth by a certified acupuncturist. The needles will be left in place until the hospital discharge of the patient on the third postpartal day, and removed by a certified acupuncturist.

Additional oral analgesics (NSAID) could be supplied at any time upon patients request during hospitalization. Oral ibuprofen would be given as first line therapy, while oral paracetamol would be given as second line therapy.

Primary outcome measures will be pain intensity (VAS score) immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity. Secondary outcome measures will be the need for analgesics, the amount of given analgesics, and the number of analgesic repetitions during the day.

In addition, subjective experiences of postpartum bleeding and pain due to uterine contractions will be recorded. For those who had received acupuncture therapy, pain levels at the acupuncture site, analysis of acupuncture related experience included discomfort during sleep, other contacts with acupuncture previously and likelihood of recommending the method to a friend will be noted. After leaving the hospital, women in the acupuncture group will be asked to fill out a questionnaire on acupuncture treatment satisfaction. All patients will sign an informed consent form. Inter-group comparisons will be performed based on the patient status at the time of hospital admission and during hospital stay. Input parameters: age, education level, number of previous births. Characteristics of delivery will be noted as: the time of birth, the duration of the birth, the subjective experience of the birth, the application of epidural analgesia.

If labor starts before 8 AM, it will be considered as the first day of the hospitalization, and if labor starts later than 8 AM, the first day of hospitalization will be documented as the next day.

Pain intensity will be evaluated using the Visual Analog Scala score. VAS score is scaled from 1 (smallest pain) to 10 (strongest pain). VAS score higher than 3 was the cut-off point for analgesic administration. The patients will be divided into two groups based on their education level; the first group encompassing women who had finished high school, and the other women who hold a university degree.

Statistical analysis The results will be expressed as a number for categorical variables and as a median value (25th-75th interquartile range) for continuous variables. Continuous variables will be compared using the Student's t-test for independent samples, while categorical variables were compared using χ2-test. Fisher's exact test will be used if expected frequencies are less than five. All statistical tests will be two tailed, and P values < 0.05 considered statistically significant. All statistical analyses will be performed using MedCalc 9.5.1.0 (MedCalc Software, Mariakerke, Belgium).

Peer-reviewed publications containing data from the study have not yet been published.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zagreb, Croatia, 10000
        • University Hospital Center Sestre milosrdnice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • healthy pregnant women over 18 years of age
  • a minimum of 36 weeks' gestation
  • patients that underwent mediolateral episiotomy during vaginal delivery

Exclusion Criteria:

  • any illness diagnosed during pregnancy
  • unwillingness to submit to acupuncture therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Ear Acupuncture and Oral Analgesics

The acupuncture treatment consisted of three acupuncture needles on the dominant ear according to French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point that is used to increase the anaesthetic effect according to both French and Chinese traditions.

Additional oral analgesics (NSAID) could be supplied at any time upon patients request during hospitalization. Oral ibuprofen was given as first line therapy, while oral paracetamol was given as second line therapy.

French auriculotherapy guidelines - internal genital area, external genital area and Shen Men point.
Other Names:
  • Ear, acupuncture
ACTIVE_COMPARATOR: Oral Analgesics Only
Postoperative standard oral analgesic therapy (NSAID) supplied at any time upon patients request during hospitalization. Oral ibuprofen would be given as first line therapy, while oral paracetamol would be given as second line therapy.
Oral ibuprofen was given as first line therapy, while oral paracetamol was given as second line therapy.
Other Names:
  • Oral analgesics

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain relief
Time Frame: Immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity.
Level of pain intensity measured by VAS - Visual Analogue Scale score ranging from 1 (smallest pain level) to 10 (highest pain level).
Immediately after birth, 2 hours after birth, during the first 3 days-at rest and activity.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oral analgesics amount
Time Frame: First 3 postpartal days.
Amount of given analgesics in miligrams per patient per day during the first 3 postpartal days.
First 3 postpartal days.
Postpartum bleeding and pain due to uterine contractions
Time Frame: First 3 postpartal days.
Subjective levels of postpartum bleeding and pain due to uterine contractions recorded.
First 3 postpartal days.
Number of analgesic repetitions during the day.
Time Frame: First 3 postpartal days.
Number of times patients required oral analgesic therapy (N).
First 3 postpartal days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Andro Košec, MD, PhD, Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Sestre milosrdnice

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2016

Primary Completion (ACTUAL)

April 30, 2017

Study Completion (ACTUAL)

April 30, 2017

Study Registration Dates

First Submitted

April 30, 2018

First Submitted That Met QC Criteria

May 11, 2018

First Posted (ACTUAL)

May 23, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 23, 2018

Last Update Submitted That Met QC Criteria

May 11, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

All statistical data gathered from the study, no identifiable patient records.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Labor

Clinical Trials on Ear acupuncture

Subscribe